Rosén S - Search Results

1

Qualification of a select one-stage activated partial thromboplastin time-based clotting assay and two chromogenic assays for the post-administration monitoring of nonacog beta pegol.

Tiefenbacher S, Bohra R, Amiral J, Bowyer A, Kitchen S, Lochu A, Rosén S, Ezban M. Tiefenbacher S, et al. Among authors: rosen s. J Thromb Haemost. 2017 Oct;15(10):1901-1912. doi: 10.1111/jth.13787. Epub 2017 Sep 11. J Thromb Haemost. 2017. PMID: 28772338 Free article.

2

Overestimation of N-glycoPEGylated factor IX activity in a one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX.

Rosén P, Rosén S, Ezban M, Persson E. Rosén P, et al. Among authors: rosen s. J Thromb Haemost. 2016 Jul;14(7):1420-7. doi: 10.1111/jth.13359. Epub 2016 Jun 22. J Thromb Haemost. 2016. PMID: 27169618 Free article.

3

Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapy.

Rosen S, Tiefenbacher S, Robinson M, Huang M, Srimani J, Mackenzie D, Christianson T, Pasi KJ, Rangarajan S, Symington E, Giermasz A, Pierce GF, Kim B, Zoog SJ, Vettermann C. Rosen S, et al. Blood. 2020 Nov 26;136(22):2524-2534. doi: 10.1182/blood.2020005683. Blood. 2020. PMID: 32915950 Free PMC article. Clinical Trial.

4

Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals. The APC Resistance Study Group.

Rosén S, Johansson K, Lindberg K, Dahlbäck B. Rosén S, et al. Thromb Haemost. 1994 Aug;72(2):255-60. Thromb Haemost. 1994. PMID: 7831662

5

FIX potency of rFIX-Albumin fusion protein is underestimated by one-stage methods using silica-based APTT reagents.

Rosén S, Bryngelhed P. Rosén S, et al. Haemophilia. 2020 Mar;26(2):340-345. doi: 10.1111/hae.13915. Epub 2020 Jan 31. Haemophilia. 2020. PMID: 32006459

6

Heparin therapy and monitoring: a role for the chromogenic antifactor Xa assay.

Rosén S, Casoni MC. Rosén S, et al. Am Clin Lab. 2001 Aug;20(7):35-8. Am Clin Lab. 2001. PMID: 11570272 Review. No abstract available.

7

Chromogenic methods in coagulation diagnostics.

Rosén S. Rosén S. Hamostaseologie. 2005 Aug;25(3):259-66. doi: 10.1267/hämo05030259. Hamostaseologie. 2005. PMID: 16113749 Review.

8

A simple and accurate microplate assay for the determination of factor VIII activity.

Carlebjörk G, Oswaldsson U, Rosén S. Carlebjörk G, et al. Among authors: rosen s. Thromb Res. 1987 Jul 1;47(1):5-14. doi: 10.1016/0049-3848(87)90235-0. Thromb Res. 1987. PMID: 3116712

9

Clinical application of a chromogenic substrate method for determination of factor VIII activity.

Rosén S, Andersson M, Blombäck M, Hägglund U, Larrieu MJ, Wolf M, Boyer C, Rothschild C, Nilsson IM, Sjörin E, et al. Rosén S, et al. Thromb Haemost. 1985 Dec 17;54(4):818-23. Thromb Haemost. 1985. PMID: 3937277

10

Evaluation of a modified APTT-based method for determination of APC resistance in plasma from patients on heparin or oral anticoagulant therapy.

Hall C, Andersson NE, Andras M, Zetterberg U, Rosén S. Hall C, et al. Among authors: rosen s. Thromb Res. 1998 Mar 1;89(5):203-9. doi: 10.1016/s0049-3848(98)00006-1. Thromb Res. 1998. PMID: 9645913 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,145 results

Search Page

Filters